Cancer innovation has been a longstanding priority in the current administration. But sometimes overlooked is some of the nation’s most sophisticated lung cancer research underway at the Department of Veterans Affairs. This includes applying capacities like modernized electronic health records and artificial intelligence to support groundbreaking innovation. Dr. Michael Kelley, director of the National Precision Oncology Program, and Kenute Myrie, portfolio manager at the VA Office of Research and Development, discuss how the agency is advancing understanding of cancer and improving long-term health outcomes for veterans.
HealthCast
Season 3
Episode 24
27m listen
How VA is Leveraging Genomics and Big Data to Improve Lung Cancer Outcomes

Lung cancer innovation at the agency is looking at technology to improve detection and treatment.

-
Dr. Michael Kelley National Program Director for Oncology VA
-
Dr. Kenute Myrie Lead for Precision Oncology, Office of Research and Development VA
Related Content
-
Boosting Cyber Resiliency in the Financial Sector
Leaders from CFPB and Rubrik discuss how they’re bolstering cyber resiliency to secure the financial sector and its critical assets.
30m watch -
AFCEA West: AI is America’s ‘Sputnik Moment,’ Defense Academic Says
NPS president says that ‘warrior scholars’ bridge research and implementable capabilities for national security.
12m listen -
Navy Research Leads Push for Tech Innovation to Stay Ahead
The Naval Research Laboratory is driving innovation to enhance readiness and maintain technological dominance against emerging threats.
3m read -
Defending the Cyber Domain in a Time of 'Non-Kinetic' Threats
Northcom's intelligence leader Brig. Gen. Maurizio Calabrese discussed the evolving role of defense intelligence technology.
20m watch